PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
IMMX vs. VMNIX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between IMMX and VMNIX is 0.00, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.0

Performance

IMMX vs. VMNIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Immix Biopharma, Inc. (IMMX) and Vanguard Market Neutral Fund Institutional Shares (VMNIX). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%20.00%AugustSeptemberOctoberNovemberDecember2025
-3.88%
0.80%
IMMX
VMNIX

Key characteristics

Sharpe Ratio

IMMX:

-0.68

VMNIX:

0.70

Sortino Ratio

IMMX:

-0.91

VMNIX:

1.07

Omega Ratio

IMMX:

0.90

VMNIX:

1.12

Calmar Ratio

IMMX:

-0.79

VMNIX:

1.18

Martin Ratio

IMMX:

-1.11

VMNIX:

2.50

Ulcer Index

IMMX:

57.79%

VMNIX:

1.74%

Daily Std Dev

IMMX:

95.18%

VMNIX:

6.27%

Max Drawdown

IMMX:

-88.89%

VMNIX:

-25.35%

Current Drawdown

IMMX:

-72.76%

VMNIX:

-1.85%

Returns By Period

In the year-to-date period, IMMX achieves a -10.00% return, which is significantly lower than VMNIX's 1.52% return.


IMMX

YTD

-10.00%

1M

-9.17%

6M

-3.88%

1Y

-57.87%

5Y*

N/A

10Y*

N/A

VMNIX

YTD

1.52%

1M

1.02%

6M

0.81%

1Y

4.90%

5Y*

8.23%

10Y*

3.33%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

IMMX vs. VMNIX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IMMX
The Risk-Adjusted Performance Rank of IMMX is 1212
Overall Rank
The Sharpe Ratio Rank of IMMX is 1212
Sharpe Ratio Rank
The Sortino Ratio Rank of IMMX is 1212
Sortino Ratio Rank
The Omega Ratio Rank of IMMX is 1414
Omega Ratio Rank
The Calmar Ratio Rank of IMMX is 55
Calmar Ratio Rank
The Martin Ratio Rank of IMMX is 1818
Martin Ratio Rank

VMNIX
The Risk-Adjusted Performance Rank of VMNIX is 3636
Overall Rank
The Sharpe Ratio Rank of VMNIX is 2828
Sharpe Ratio Rank
The Sortino Ratio Rank of VMNIX is 3131
Sortino Ratio Rank
The Omega Ratio Rank of VMNIX is 2323
Omega Ratio Rank
The Calmar Ratio Rank of VMNIX is 6969
Calmar Ratio Rank
The Martin Ratio Rank of VMNIX is 3131
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

IMMX vs. VMNIX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Immix Biopharma, Inc. (IMMX) and Vanguard Market Neutral Fund Institutional Shares (VMNIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for IMMX, currently valued at -0.68, compared to the broader market-2.000.002.004.00-0.680.70
The chart of Sortino ratio for IMMX, currently valued at -0.91, compared to the broader market-4.00-2.000.002.004.006.00-0.911.07
The chart of Omega ratio for IMMX, currently valued at 0.90, compared to the broader market0.501.001.502.000.901.12
The chart of Calmar ratio for IMMX, currently valued at -0.79, compared to the broader market0.002.004.006.00-0.791.18
The chart of Martin ratio for IMMX, currently valued at -1.11, compared to the broader market0.0010.0020.0030.00-1.112.50
IMMX
VMNIX

The current IMMX Sharpe Ratio is -0.68, which is lower than the VMNIX Sharpe Ratio of 0.70. The chart below compares the historical Sharpe Ratios of IMMX and VMNIX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
-0.68
0.70
IMMX
VMNIX

Dividends

IMMX vs. VMNIX - Dividend Comparison

IMMX has not paid dividends to shareholders, while VMNIX's dividend yield for the trailing twelve months is around 5.59%.


TTM2024202320222021202020192018201720162015
IMMX
Immix Biopharma, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VMNIX
Vanguard Market Neutral Fund Institutional Shares
5.59%5.67%5.15%0.78%0.20%0.85%3.22%1.00%1.16%0.45%0.10%

Drawdowns

IMMX vs. VMNIX - Drawdown Comparison

The maximum IMMX drawdown since its inception was -88.89%, which is greater than VMNIX's maximum drawdown of -25.35%. Use the drawdown chart below to compare losses from any high point for IMMX and VMNIX. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-72.76%
-1.85%
IMMX
VMNIX

Volatility

IMMX vs. VMNIX - Volatility Comparison

Immix Biopharma, Inc. (IMMX) has a higher volatility of 18.28% compared to Vanguard Market Neutral Fund Institutional Shares (VMNIX) at 1.88%. This indicates that IMMX's price experiences larger fluctuations and is considered to be riskier than VMNIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%AugustSeptemberOctoberNovemberDecember2025
18.28%
1.88%
IMMX
VMNIX
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab